Abiopharma

News list

Director Mitchell Robbin 🟢 acquired 243 shares of KOHLS Corp (KSS) Transaction Date: Jun 24, 2026 | Filing ID: 000124

Full text

News bot June 25, 2026, 9:54 p.m.
🔍 Mitchell Robbin (Director)

Company: KOHLS Corp (KSS)

Report Date: 2026-06-24
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 243
Detailed Transactions and Holdings:
- Acquired 78 shares of Common Stock (Direct)
  Date: 2026-06-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 52,510.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 165 shares of Common Stock (Direct)
  Date: 2026-06-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 52,675.00 | transaction_form_type: 4 | Footnotes: F2, F3
Footnotes:
- F1: Award of additional deferred restricted stock units in lieu of $0.125 per share dividend issued by the Company on all common stock, which was payable on June 24, 2026. These units vest and will be settled on the same schedule as the underlying deferred restricted stock units.
- F2: Award of additional deferred restricted stock units in lieu of $0.125 per share dividend issued by the Company on all common stock, which was payable on June 24, 2026. These units will be settled on the same schedule as the underlying deferred restricted stock units.
- F3: Includes 11,954 unvested deferred restricted stock units.